» Molekularne i komórkowe parametry w gruźlicy

*Magdalena Druszczyńska, Dominik Strapagiel, Wiesława Rudnicka

Molekularne i komórkowe parametry w gruźlicy

Molecular and cellular parameters in tuberculosis

Zakład Immunologii Komórkowej, Katedra Immunologii i Biologii Infekcyjnej, Uniwersytet Łódzki
Kierownik Katedry: prof. dr hab Wiesława Rudnicka

Summary

Key words:

Piśmiennictwo

1. Hoal van Helden EG et al.: Diversity of in vitro cytokine responses by human macrophages to infection by Mycobacterium tuberculosis strains. Cell Biol. Int. 2001; 25: 83-90. 2. Lykouras D: Human genes in TB infection: their role in immune response. Monaldi Arch. Chest Dis. 2008; 69: 24-31. 3. Salgame P: Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr. Opin. Immunol. 2005; 17: 374-80. 4. Glickman MS, Jacobs WR Jr.: Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 2001; 104: 477-85. 5. Verreck FA et al.: Human IL-23 producing type 1 macrophages promote but IL-10 producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 2004; 101: 4560-65. 6. van de Vosse E, Hoeve MA: Ottenhoff TH: Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect. Dis. 2004; 4: 739-49. 7. O´Neill LA: How Toll-like receptors signal: what we know and what we don´t know. Curr. Opin. Immunol. 2006; 18: 3-9. 8. van Crevel R, Ottenhoff TH, van der Meer JW: Innate immunity to Mycobacterium tuberculosis. Clin. Microbial. Rev. 2002; 15; 294-09. 9. Krutzik SR, Modlin RL: The role of Toll-like receptors in combating mycobacteria. Semin. Immunol. 2004; 16: 35-41. 10. Blackwell JM et al.: Immunogenetics of leishmanial and mycobacterial infection: the Belem family study. Philos Trans. R Soc. Lond B Biol. Sci. 1997; 352: 1331-1345. 11. Bellamy R et al.: Variations in the Nramp1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med., 1998; 338: 640-644. 12. Soborg C et al.: Natural resistance-associated macrophage protein 1 polymorphisms are associated with microscopy-positive tuberculosis. J. Infect. Dis. 2002; 186: 517-21. 13. Greenwood CMT et al.: Linkage of tuberculosis to chromosome 2q35 loci, including Canadian family. Am. J. Hum. Genet. 200067, 405-416. 14. Ryu YJ et al.: Toll-like receptor 2 polymorphisms and nontuberculous mycobacterial lung disease; Clin. Vaccine Immunol. 2006; 13: 818-19. 15. Ogus AC et al.: The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J. 2004; 23: 219-23. 16. Texereau J et al.: The importance of Toll-like receptor 2 polymorphisms in severe infections; Clin. Infect. Dis. 2005; 41: 408-15. 17. van der Graaf CA et al.: Candida-specific interferon-gamma deficiency and toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis; Neth. J. Med. 2003; 61: 365-69. 18. Bellamy RB, Hill AV: Genetic susceptibility to mycobacteria and other infectious pathogens in humans. Curr. Opin. Immunol. 1998; 10: 483-487. 19. Mombo LE et al.: Mannose-binding lectin alleles in sub-Saharan Africans and relation with susceptibility to infections; Genes Immun. 2003; 4: 362-67. 20. Selvaraj P, Narayanan PR, Reetha AM: Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India. Tuber. Lung Dis. 1999; 79: 221-27. 21. Madsen HO et al.: Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein; J. Immunol. 1995; 155: 3013-20. 22. Druszczyńska M et al.: Tuberculosis bacilli still posing a threat. Polymorphism of genes regulating anti-microbial properties of macrophages. Pol. J. Microbiol. 2006; 55: 7-12. 23. Baldini M et al.: A polymorphism in the 5´ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell Mol. Biol. 1999; 20: 976-83. 24. Rosas-Taraco AG et al.: CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis; J. Infect. Dis. 2007; 196: 1698-706. 25. Pacheco E et al.: CD14 gene promoter polymorphism in different clinical forms of tuberculosis. FEMS Immunol. Med. Microbiol. 2004; 40: 207-13. 26. Shutt C: Molecules in focus CD14. Int. J. Biochem. Cell Biol. 1999; 31: 545-49. 27. Joyce DA, Steer JH, Abraham LJ: Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion. Inflamm. Res. 1997; 46: 447-51. 28. Vanham G et al.: Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy. Tuber. Lung Dis. 1997; 78: 145-58.

otrzymano/received: 2009-02-25
zaakceptowano/accepted: 2009-03-27

Adres/address:
*Magdalena Druszczyńska
Katedra Immunologii i Biologii Infekcyjnej,Zakład Immunologii Komórkowej, Uniwersytet Łódzki
ul. Banacha 12/16, 90-237 Łódź
tel.: (0-42) 635-44-70
e-mail: majur@biol.uni.lodz.pl

Pełna wersja artykułu Molekularne i komórkowe parametry w gruźlicy dostępna w Czytelni Medycznej Borgis.

Copyright © Wydawnictwo Medyczne Borgis Sp. z o.o. 2007-2013
Chcesz być na bieżąco? Polub nas na Facebooku: strona Wydawnictwa na Facebooku